암 치료 시장 : 치료 유형별, 암 유형별, 지역별

Global Cancer Therapy Market is estimated to be valued at USD 230.96 Bn in 2025 and is expected to reach USD 530.37 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.6% from 2025 to 2032.

Figure. Cancer Therapy Market Share (%), By Region 2025

Cancer continues to pose significant healthcare challenges worldwide. Rapidly aging population profiles in numerous countries have contributed to the rising cancer prevalence. Furthermore, increasing environmental pollution levels and lifestyle changes such as unhealthy diets, lack of physical activity, tobacco use, and alcohol consumption have elevated the cancer risk in populations. Despite advancements in therapeutic interventions, cancer mortality remains substantial. As a result, drug development activity in the oncology sector has intensified in recent times focused on improving patient outcomes and quality of life.

Market Dynamics:

The cancer therapy market is driven by various factors such as the increasing prevalence of cancer worldwide owing to changing lifestyle patterns, growing geriatric population, increasing adoption of targeted therapies and personalized medicine, expansion of healthcare infrastructure across emerging nations, and rising investment in cancer R&D by pharmaceutical companies. However, high treatment costs associated with cancer care pose limitations to widespread adoption. Moreover, long regulatory approval timelines for new drug approvals also challenge market growth to some extent. Meanwhile, robust cancer clinical trial pipelines and the entry of biosimilars provide significant opportunities for market expansion over the forecast period.

Key Features of the Study:

• This report provides an in-depth analysis of the global cancer therapy market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global cancer therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study includes Bristol-Myers Squibb Company, AstraZeneca, Pfizer Inc., Novartis AG, GSK plc., Sanofi, Bayer AG, Amgen Inc., Gilead Sciences, Inc., Boehringer Ingelheim International GmbH., ADC Therapeutics SA, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Eureka Therapeutics, Inc., AbbVie Inc., Fate Therapeutics, Sorrento Therapeutics, Inc., Carrick Therapeutics Limited, Atara Biotherapeutics, Inc., Celluris, NeoTX, and Kazia Therapeutics Limited.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global cancer therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer therapy market.

Detailed Segmentation-

• Therapy Type:
  • Chemotherapy
  • Alkylating agents
  • Antimetabolites
  • Anti-tumor antibiotics
  • Others
  • Target Therapy
  • Monoclonal antibodies
  • Small molecule inhibitors
  • Others
  • Immunotherapy
  • Immune Checkpoint Inhibitors
  • Oncolytic virus therapy
  • T-cell therapy
  • Radiotherapy
  • Others
• Cancer Type:
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Blood Cancer
  • Liver Cancer
  • Thyroid Cancer
  • Head and Neck Cancer
  • Skin Cancer
  • Others
• Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • AstraZeneca
  • Pfizer Inc.
  • Novartis AG
  • GSK plc.
  • Sanofi
  • Bayer AG
  • Amgen Inc.
  • Gilead Sciences, Inc.
  • Boehringer Ingelheim International GmbH.
  • ADC Therapeutics SA
  • Hoffmann-La Roche Ltd
  • Merck & Co., Inc.
  • Eureka Therapeutics, Inc.
  • AbbVie Inc.
  • Fate Therapeutics
  • Sorrento Therapeutics, Inc.
  • Carrick Therapeutics Limited
  • Atara Biotherapeutics, Inc.
  • Celluris
  • NeoTX
  • Kazia Therapeutics Limited

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Therapy Type
  • Market Snapshot, By Cancer Type
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Acquisitions and Partnerships Scenario
• Reimbursement Scenario
• Epidemiology
• Treatment Algorithm (Patient Journey)
• Cancer Diagnosis and Treatment Options
• Pipeline Analysis
• Patient Advocacy and Empowerment
• Regulatory Scenario
• Pricing Analysis
• PEST Analysis
• PORTER's Analysis

4. Global Cancer Therapy Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 impact on the market

5. Global Cancer Therapy Market, By Therapy Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Chemotherapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Alkylating agents
• Antimetabolites
• Anti-tumor antibiotics
• Others
• Target Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Monoclonal antibodies
• Small molecule inhibitors
• Others
• Immunotherapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Immune Checkpoint Inhibitors
• Oncolytic virus therapy
• T-cell therapy
• Radiotherapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Cancer Therapy Market, By Cancer Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Breast Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Lung Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Colorectal Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Prostate Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Blood Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Liver Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Thyroid Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Head and Neck Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Skin Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Cancer Therapy Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • Bristol-Myers Squibb Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AstraZeneca
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GSK plc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi
  • Bayer AG
  • Amgen Inc.
  • Gilead Sciences, Inc.
  • Boehringer Ingelheim International GmbH.
  • ADC Therapeutics SA
  • F. Hoffmann-La Roche Ltd
  • Merck & Co., Inc.
  • Eureka Therapeutics, Inc.
  • AbbVie Inc.
  • Fate Therapeutics
  • Sorrento Therapeutics, Inc.
  • Carrick Therapeutics Limited
  • Atara Biotherapeutics, Inc.
  • Celluris
  • NeoTX
  • Kazia Therapeutics Limited

9. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact